Role of the interaction between galectin-3 and cell adhesion molecules in cancer metastasis

Biomedicine and Pharmacotherapy

Volumn 69, Issue , 2015, Pages 179-185

  Xin, Ming ^a   Dong, Xin Wen ^a   Guo, Xiu Li ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

CAMs; Galectin 3; Metastasis; Muc1

Indexed keywords

CADHERIN; CD18 ANTIGEN; CD98 ANTIGEN; CELL ADHESION MOLECULE; DESMOGLEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPIDERMAL GROWTH FACTOR RECEPTOR; GALECTIN 3; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; LIIVER INTESTINE CADHERIN; MESSENGER RNA; MUCIN 1; NERVE CELL ADHESION MOLECULE; THOMSEN FRIEDENREICH GLYCOANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG; UVOMORULIN; VASCULAR CELL ADHESION MOLECULE 1; VASCULAR ENDOTHELIAL CADHERIN; VERY LATE ACTIVATION ANTIGEN 1; PROTEIN BINDING;

ANGIOGENESIS; CANCER CELL; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CELL SURFACE; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME MECHANISM; EXTRACELLULAR MATRIX; GENE CLUSTER; GLYCOSYLATION; HUMAN; METASTASIS; MODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; SIALYLATION; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; METABOLISM; PATHOLOGY;

ANIMALS; CELL ADHESION MOLECULES; GALECTIN 3; HUMANS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; PROTEIN BINDING;

EID: 84922233366     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2014.11.024     Document Type: Review

References (62)

1. Dumic J., Dabelic S., Flogel M. Galectin-3: an open-ended story. Biochim Biophys Acta 2006, 1760(4):616-635.
2. Ochieng J., Furtak V., Lukyanov P. Extracellular functions of galectin-3. Glycoconj J 2004, 19(7-9):527-535.
3. Li D.M., Feng Y.M. Signaling mechanism of cell adhesion molecules in breast cancer metastasis: potential therapeutic targets. Breast Cancer Res Treat 2011, 128(1):7-21.
4. Makrilia N., Kollias A., Manolopoulos L., Syrigos K. Cell adhesion molecules: role and clinical significance in cancer. Cancer Invest 2009, 27(10):1023-1037.
5. Takenaka Y., Fukumori T., Raz A. Galectin-3 and metastasis. Glycoconj J 2004, 19(7-9):543-549.
6. Boscher C., Zheng Y.Z., Lakshminarayan R., Johannes L., Dennis J.W., Foster L.J., et al. Galectin-3 protein regulates mobility of N-cadherin and GM1 ganglioside at cell-cell junctions of mammary carcinoma cells. J Biol Chem 2012, 287(39):32940-32952.
7. de Oliveira J.T., de Matos A.J., Santos A.L., Pinto R., Gomes J., Hespanhol V., et al. Sialylation regulates galectin-3/ligand interplay during mammary tumour progression-a case of targeted uncloaking. Int J Dev Biol 2011, 55(7-9):823-834.
8. Rathinam R., Alahari S.K. Important role of integrins in the cancer biology. Cancer Metastasis Rev 2010, 29(1):223-237.
9. Berrier A.L., Yamada K.M. Cell-matrix adhesion. J Cell Physiol 2007, 213(3):565-573.
10. Liu F.T., Rabinovich G.A. Galectins as modulators of tumour progression. Nat Rev Cancer 2005, 5(1):29-41.
11. Matarrese P., Fusco O., Tinari N., Natoli C., Liu F.T., Semeraro M.L., et al. Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int J Cancer 2000, 85(4):545-554.
12. Furtak V., Hatcher F., Ochieng J. Galectin-3 mediates the endocytosis of beta-1 integrins by breast carcinoma cells. Biochem Biophys Res Commun 2001, 289(4):845-850.
13. Hughes R.C. Galectins as modulators of cell adhesion. Biochimie 2001, 83(7):667-676.
14. Feral C.C., Nishiya N., Fenczik C.A., Stuhlmann H., Slepak M., Ginsberg M.H. CD98hc (SLC3A2) mediates integrin signaling. Proc Natl Acad Sci U S A 2005, 102(2):355-360.
15. Cantor J.M., Ginsberg M.H. CD98 at the crossroads of adaptive immunity and cancer. J Cell Sci 2012, 125(Pt 6):1373-1382.
16. Soung Y.H., Clifford J.L., Chung J. Crosstalk between integrin and receptor tyrosine kinase signaling in breast carcinoma progression. BMB Rep 2010, 43(5):311-318.
17. Dennis J.W., Lau K.S., Demetriou M., Nabi I.R. Adaptive regulation at the cell surface by N-glycosylation. Traffic 2009, 10(11):1569-1578.
18. Boscher C., Nabi I.R. Galectin-3- and phospho-caveolin-1-dependent outside-in integrin signaling mediates the EGF motogenic response in mammary cancer cells. Mol Biol Cell 2013, 24(13):2134-2145.
19. Margadant C., van den Bout I., van Boxtel A.L., Thijssen V.L., Sonnenberg A. Epigenetic regulation of galectin-3 expression by beta1 integrins promotes cell adhesion and migration. J Biol Chem 2012, 287(53):44684-44693.
20. Friedrichs J., Manninen A., Muller D.J., Helenius J. Galectin-3 regulates integrin alpha2beta1-mediated adhesion to collagen-I and -IV. J Biol Chem 2008, 283(47):32264-32272.
21. Andrews J.L., Kim A.C., Hens J.R. The role and function of cadherins in the mammary gland. Breast Cancer Res 2012, 14(1):203.
22. Takamura M., Sakamoto M., Ino Y., Shimamura T., Ichida T., Asakura H., et al. Expression of liver-intestine cadherin and its possible interaction with galectin-3 in ductal adenocarcinoma of the pancreas. Cancer Sci 2003, 94(5):425-430.
23. Shimura T., Takenaka Y., Tsutsumi S., Hogan V., Kikuchi A., Raz A. Galectin-3, a novel binding partner of beta-catenin. Cancer Res 2004, 64(18):6363-6367.
24. Wu Z.H., Gan L. [Association of galectin-3 and E-cadherin expressions with lymph node metastasis of colon cancer]. Nan Fang Yi Ke Da Xue Xue Bao 2007, 27(11):1731-1733.
25. Khayyata S., Basturk O., Adsay N.V. Invasive micropapillary carcinomas of the ampullo-pancreatobiliary region and their association with tumor-infiltrating neutrophils. Mod Pathol 2005, 18(11):1504-1511.
26. Theveneau E., Mayor R. Cadherins in collective cell migration of mesenchymal cells. Curr Opin Cell Biol 2012, 24(5):677-684.
27. Abalsamo L., Spadaro F., Bozzuto G., Paris L., Cecchetti S., Lugini L., et al. Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells. Breast Cancer Res 2012, 14(2):R50.
28. Cavallaro U., Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 2004, 4(2):118-132.
29. Giebultowicz J., Polanska-Plachta M., Wroczynski P., Zaborowski P., Polanski J.A. How echinoccocosis affects potential cancer markers in plasma: galectin-3, sN-cadherin and sE-cadherin? A preliminary report. Diagn Pathol 2012, 7:17.
30. Vayssade M., Sengkhamparn N., Verhoef R., Delaigue C., Goundiam O., Vigneron P., et al. Antiproliferative and proapoptotic actions of okra pectin on B16F10 melanoma cells. Phytother Res 2010, 24(7):982-989.
31. Mourad-Zeidan A.A., Melnikova V.O., Wang H., Raz A., Bar-Eli M. Expression profiling of galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry. Am J Pathol 2008, 173(6):1839-1852.
32. Paulis Y.W., Soetekouw P.M., Verheul H.M., Tjan-Heijnen V.C., Griffioen A.W. Signalling pathways in vasculogenic mimicry. Biochim Biophys Acta 2010, 1806(1):18-28.
33. Takamura M., Yamagiwa S., Matsuda Y., Ichida T., Aoyagi Y. Involvement of liver-intestine cadherin in cancer progression. Med Mol Morphol 2013, 46(1):1-7.
34. Dong W.G., Yu Q.F., Xu Y., Fan L.F. Li-cadherin is inversely correlated with galectin-3 expression in gastric cancer. Dig Dis Sci 2008, 53(7):1811-1817.
35. Nath S., Mukherjee P. MUC1: a multifaceted oncoprotein with a key role in cancer progression. Trends Mol Med 2014, 20(6):332-342.
36. Byrd J.C., Bresalier R.S. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 2004, 23(1-2):77-99.
37. Michel A.K., Nangia-Makker P., Raz A., Cloninger M.J. Lactose-functionalized dendrimers arbitrate the interaction of galectin-3/muc1 mediated cancer cellular aggregation. Chembiochem 2014, 15(14):2106-2112.
38. Zhao Q., Guo X., Nash G.B., Stone P.C., Hilkens J., Rhodes J.M., et al. Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface. Cancer Res 2009, 69(17):6799-6806.
39. Yu L.G. The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression. Glycoconj J 2007, 24(8):411-420.
40. Gassmann P., Kang M.L., Mees S.T., Haier J. In vivo tumor cell adhesion in the pulmonary microvasculature is exclusively mediated by tumor cell-endothelial cell interaction. BMC Cancer 2010, 10:177.
41. Heimburg J., Yan J., Morey S., Glinskii O.V., Huxley V.H., Wild L., et al. Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11. Neoplasia 2006, 8(11):939-948.
42. Yu L.G., Andrews N., Zhao Q., McKean D., Williams J.F., Connor L.J., et al. Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. J Biol Chem 2007, 282(1):773-781.
43. Zou J., Glinsky V.V., Landon L.A., Matthews L., Deutscher S.L. Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion. Carcinogenesis 2005, 26(2):309-318.
44. Glinskii O.V., Sud S., Mossine V.V., Mawhinney T.P., Anthony D.C., Glinsky G.V., et al. Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucine. Neoplasia 2012 Jan, 14(1):65-73.
45. Tanida S., Mori Y., Ishida A., Akita K., Nakada H. Galectin-3 binds to MUC1-N-terminal domain and triggers recruitment of beta-catenin in MUC1-expressing mouse 3T3 cells. Biochim Biophys Acta 2014, 1840(6):1790-1797.
46. Saeland E., Belo A.I., Mongera S., van Die I., Meijer G.A., van Kooyk Y. Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients. Int J Cancer 2012, 131(1):117-128.
47. Storr S.J., Royle L., Chapman C.J., Hamid U.M., Robertson J.F., Murray A., et al. The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum. Glycobiology 2008, 18(6):456-462.
48. Rhodes J.M., Campbell B.J., Yu L.G. Lectin-epithelial interactions in the human colon. Biochem Soc Trans 2008, 36(Pt 6):1482-1486.
49. Holikova Z., Hrdlickova-Cela E., Plzak J., Smetana K., Betka J., Dvorankova B., et al. Defining the glycophenotype of squamous epithelia using plant and mammalian lectins. Differentiation-dependent expression of alpha2,6- and alpha2,3-linked N-acetylneuraminic acid in squamous epithelia and carcinomas, and its differential effect on binding of the endogenous lectins galectins-1 and -3. APMIS 2002, 110(12):845-856.
50. Picco G., Julien S., Brockhausen I., Beatson R., Antonopoulos A., Haslam S., et al. Over-expression of ST3Gal-I promotes mammary tumorigenesis. Glycobiology 2010, 20(10):1241-1250.
51. Schindlbeck C., Stellwagen J., Jeschke U., Karsten U., Rack B., Janni W., et al. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen. Clin Exp Metastasis 2008, 25(3):233-240.
52. Ramasamy S., Duraisamy S., Barbashov S., Kawano T., Kharbanda S., Kufe D. The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop. Mol Cell 2007, 27(6):992-1004.
53. Merlin J., Stechly L., de Beauce S., Monte D., Leteurtre E., van Seuningen I., et al. Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells. Oncogene 2011, 30(22):2514-2525.
54. Solatycka A., Owczarek T., Piller F., Piller V., Pula B., Wojciech L., et al. MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 beta1,6-N-acetylglucosaminyltransferase and beta-galactoside alpha2,3-sialyltransferase. Glycobiology 2012, 22(8):1042-1054.
55. Partridge E.A., Le Roy C., Di Guglielmo G.M., Pawling J., Cheung P., Granovsky M., et al. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 2004, 306(5693):120-124.
56. Li Y., Ren J., Yu W., Li Q., Kuwahara H., Yin L., et al. The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin. J Biol Chem 2001, 276(38):35239-35242.
57. Kufe D.W. MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches. Oncogene 2013, 32(9):1073-1081.
58. Ose R., Oharaa O., Nagase T. Galectin-1 and galectin-3 mediate protocadherin-24-dependent membrane localization of beta-catenin in colon cancer cell line HCT116. Curr Chem Genomics 2012, 6:18-26.
59. Chen C., Duckworth C.A., Zhao Q., Pritchard D.M., Rhodes J.M., Yu L.G. Increased circulation of galectin-3 in cancer induces secretion of metastasis-promoting cytokines from blood vascular endothelium. Clin Cancer Res 2013, 19(7):1693-1704.
60. Silverman A.M., Nakata R., Shimada H., Sposto R., DeClerck Y.A. A galectin-3-dependent pathway upregulates interleukin-6 in the microenvironment of human neuroblastoma. Cancer Res 2012, 72(9):2228-2238.
61. Jiang K., Rankin C.R., Nava P., Sumagin R., Kamekura R., Stowell S.R., et al. Galectin-3 regulates desmoglein-2 and intestinal epithelial intercellular adhesion. J Biol Chem 2014, 289(15):10510-10517.
62. Nieminen J., St-Pierre C., Sato S. Galectin-3 interacts with naive and primed neutrophils, inducing innate immune responses. J Leukoc Biol 2005, 78(5):1127-1135.